CD4 and myeloid sarcoma: The CIBERSORT and TIDE algorithms were conducted to predict TME and the significant difference of CD4 + T cells, B cells, neutrophils, and cancer-associated fibroblasts (CAFs) between the high and low MS group (all p < 0.01, Fig. 4A-F).